News | Cardiac Diagnostics | April 07, 2016

Decision Aid Tool Improves Education for Emergency Chest Pain Patients

Mayo Clinic study shows patients who thoroughly discuss treatment with physician have improved knowledge of health status, follow-up options

Chest Pain Choice, emergency department, Mayo Clinic study, ACC 2016

April 7, 2016 — Emergency department patients with low-risk chest pain show improved knowledge of their health status and follow-up options after talking through treatment options with a physician, according to Mayo Clinic research. The study, presented at the American College of Cardiology (ACC) 65th Annual Scientific Session, compared these patients with those who received standard counseling from a physician.

Chest pain accounts for about 8 million emergency department visits each year in the United States, but more than 90 percent of those patients are not experiencing a heart attack, said Erik Hess, M.D., lead author and emergency medicine physician at Mayo Clinic. “An electrocardiogram and blood tests can tell us if a patient is having a heart attack. Further testing may be needed to tell us if a patient faces an increased risk of heart attack in the near future. We wanted to know if there is value in discussing this further testing with patients.”

In the study, which involved 898 patients visiting six emergency departments in five states, half of the patients were randomly assigned to receive a physician discussion using Chest Pain Choice, the first patient-oriented tool designed to help shared decision-making between patients and physicians for chest pain. Patients were shown one-page information sheets that provide descriptions and graphics depicting a patient’s specific risk, such as a 2 percent risk of having a heart attack in the next 45 days and the next steps for care.

Results showed that patients who received Chest Pain Choice increased their knowledge about their risk and options, answering 53 percent of questions on a questionnaire correctly, compared with 44.6 percent in the patients who received standard physician consultation. In addition, patients were asked to evaluate the experience of discussing their care with their physician. Of patients who received Chest Pain Choice, 68.9 percent said they would recommend the way they discussed care and options with their physicians, compared with 61.2 percent of those who received standard care.

“This trial shows that patient engagement in care can be beneficial to the patient’s understanding and treatment, and can lead to better care and more efficient use of resources,” Hess said, adding that Chest Pain Choice was associated with no major adverse heart events and led to a significantly lower proportion of patients receiving a stress test.

Co-authors are: Judd Hollander, M.D., Thomas Jefferson University; Jason Schaeffer, M.D., and Jeff Kline, M.D., both of Indiana University Bloomington; Deborah Diercks, M.D., University of Texas Southwestern; Russell Jones M.D., University of California, Davis; Jeph Herrin Ph.D., Yale University School of Medicine; Michel Demers; and Nilay Shah, Ph.D., Jonathan Inselman, Carlos Torres, M.D., Ph.D., Annie LeBlanc Ph.D., Ana Castaneda-Guarderas M.D., and Victor Montori, M.D., all of Mayo Clinic.

The study was funded by Patient-Centered Outcomes Research Institute and Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery.

For more information: www.acc.org

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init